Abstract
Beckwith–Wiedemann syndrome (BWS) is an overgrowth disorder involving developmental abnormalities, tissue and organ hyperplasia and an increased risk of embryonal tumours (most commonly Wilms tumour). This multigenic disorder is caused by dysregulation of the expression of imprinted genes in the 11p15 chromosomal region. Molecular diagnosis of BWS is currently difficult, mostly due to the large spectrum of genetic and epigenetic abnormalities. The other difficulty in managing BWS is the identification of patients at risk of tumour. An imprinted antisense transcript within KCNQ1, called KCNQ1OT (also known as LIT1), was recently shown to be normally expressed from the paternal allele. A loss of imprinting of the KCNQ1OT gene, associated with the loss of maternal allele-specific methylation of the differentially methylated region KvDMR1 has been described in BWS patients. The principal aim of this study was to evaluate the usefulness of KvDMR1 methylation analysis of leukocyte DNA for the diagnosis of BWS. The allelic status of the 11p15 region and the methylation status of the KCNQ1OT and H19 genes were investigated in leukocyte DNA from 97 patients referred for BWS and classified into two groups according to clinical data: complete BWS (CBWS) (n=61) and incomplete BWS (IBWS) (n=36). Fifty-eight (60%) patients (39/61 CBWS and 19/36 IBWS) displayed abnormal demethylation of KvDMR1. In 11 of the 56 informative cases, demethylation of KvDMR1 was related to 11p15 uniparental disomy (UPD) (nine CBWS and two IBWS). Thirteen of the 39 patients with normal methylation of KvDMR1 displayed hypermethylation of the H19 gene. These 13 patients included two siblings with 11p15 trisomy. These results show that analysis of the methylation status of KvDMR1 and the H19 gene in leukocyte DNA is useful in the diagnosis of 11p15-related overgrowth syndromes, resulting in the diagnosis of BWS in more than 70% of investigated patients. We also evaluated clinical and molecular features as prognostic factors for tumour and showed that mosaicism for 11p15 UPD and hypermethylation of the H19 gene in blood cells were associated with an increased risk of tumour.
Similar content being viewed by others
Article PDF
References
Pettenati M, Haines J, Higgins R, Wappner R, Palmer C, Weaver D: Wiedemann–Beckwith syndrome: presentation of clinical, cytogenetic data on 22 new cases, review of the literature . Hum Genet 1986 74: 143–154
Elliot M, Maher E . Beckwith–Wiedemann syndrome J Med Genet 1994 31: 560–564
Li M, Squire J, Weksberg R . Molecular genetics of Wiedemann–Beckwith syndrome Am J Med Genet 1998 79: 253–259
Morison I, Becroft D, Taniguchi T, Woods C, Reeve A . Somatic overgrowth associated with overexpression of insulin-like growth factor II Nat Genet 1996 2: 311–316
Hoyme HE, Seaver LH, Jones KL, Procopio F, Crooks W, Feingold M . Isolated hemihyperplasia (hemihypertrophy): report of a prospective multicenter study of the incidence of neoplasia and review Am J Med Genet 1998 79: 274–278
Morison IM, Reeve AE . Insulin-like growth factor 2 and overgrowth: molecular biology and clinical implications Mol Med Today 1998 4: 110–115
Maher ER, Reik W . Beckwith–Wiedemann syndrome: imprinting in clusters revisited J Clin Invest 2000 105: 247–252
Smilinich N, Day C, Fitzpatrick G et al. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith–Wiedemann syndrome Proc Natl Acad Sci USA 1999 96: 8064–8069
Lee M, Debaun M, Mitsuya K et al. Loss of imprinting of a paternally expressed transcript, with antisense orientation to KvLQT1, occurs frequently in Beckwith–Wiedemann syndrome and is independent of insuline-like growth factor II imprinting Proc Natl Acad Sci USA 1999 96: 5203–5208
Mitsuya K, Meguro M, Lee M et al. LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids Hum Mol Genet 1999 8: 1209–1217
Horike S, Mitsuya K, Meguro M et al. Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith–Wiedemann syndrome Hum Mol Genet 2000 9: 2075–2083
Sotelo-Avila C, Gonzalez-Crussi F, Fowler J . Complete and incomplete forms of Beckwith–Wiedemann syndrome: their oncogenic potential J Pediatr 1980 96: 47–50
Wiedemann H . Tumors and hemihypertrophy associated with Wiedemann–Beckwith syndrome Eur J Pediatr 1983 141: 129
DeBaun MR, Tucker MA . Risk of cancer during the first four years of life in children from the Beckwith–Wiedemann syndrome registry J Pediatr 1998 132: 398–400
Schneid H, Vazquez MP, Vacher C, Gourmelen M, Cabrol S, Le Bouc Y . The Beckwith–Wiedemann syndrome phenotype and the risk of cancer Med Pediatr Oncol 1997 28: 411–415
DeBaun MR, Siegel MJ, Choyke PL . Nephromegaly in infancy and early childhood: a risk factor for Wilms tumor in Beckwith–Wiedemann syndrome J Pediatr 1998 132: 401–404
Henry I, Puech A, Riesewijk A et al. Somatic mosaicism for partial paternal isodisomy in Wiedemann–Beckwith syndrome: a post-fertilization event Eur J Hum Genet 1993 1: 19–29
Schneid H, Seurin D, Vazquez M, Gourmelen M, Cabrol S, Le Bouc Y . Parental allele specific methylation of the human insulin-like growth factor II gene and Beckwith–Wiedemann syndrome J Med Genet 1993 30: 353–362
Gicquel C, Le Bouc Y, Luton J, Girard F, Bertagna X . Monoclonality of corticotroph macroadenomas in Cushing's disease J Clin Endocrinol Metab 1992 75: 472–475
Gicquel C, Bertagna X, Schneid H et al. Rearrangements at 11p15 locus and overexpression of Insulin like growth factor-II gene in sporadic adrenocortical tumors J Clin Endocrinol Metab 1994 78: 1444–1453
Reik W, Brown KW, Slatter RE, Sartori P, Elliott M, Maher ER . Allelic methylation of H19 and IGF2 in the Beckwith–Wiedemann syndrome Hum Mol Genet 1994 3: 1297–1301
Brannan C, Dees E, Ingram R, Tilghman S . The product of the H19 gene may function as a RNA Mol Cell Biol 1990 10: 28–36
Collet D . Modelling survival data in medical research In: Text in statistical science Chapman and Hall, London 1994
Engel J, Smallwood A, Harper A et al. Epigenotype-phenotype correlations in Beckwith–Wiedemann syndrome J Med Genet 2000 37: 921–926
Itoh N, Becroft DM, Reeve AE, Morison IM . Proportion of cells with paternal 11p15 uniparental disomy correlates with organ enlargement in Wiedemann–Beckwith syndrome Am J Med Genet 2000 92: 111–116
Clayton-Smith J, Read AP, Donnai D . Monozygotic twinning and Wiedemann–Beckwith syndrome Am J Med Genet 1992 42: 633–637
Franceschini P, Guala A, Vardeu MP, Franceschini D . Monozygotic twinning and Wiedemann–Beckwith syndrome Am J Med Genet 1993 46: 353–354
Leonard NJ, Bernier FP, Rudd N et al. Two pairs of male monozygotic twins discordant for Wiedemann–Beckwith syndrome Am J Med Genet 1996 61: 253–257
Orstavik RE, Tommerup N, Eiklid K, Orstavik KH . Non-random X chromosome inactivation in an affected twin in a monozygotic twin pair discordant for Wiedemann–Beckwith syndrome Am J Med Genet 1995 56: 210–214
Tycko B . Epigenetic gene silencing in cancer J Clin Invest 2000 105: 401–407
Gaston V, Le Bouc Y, Soupre V, Vazquez M, Gicquel C . Assessment of p57KIP2 gene mutation in Wiedemann–Beckwith syndrome Horm Res 2000 54: 1–5
Eggenschwiler J, Ludwig T, Fisher P, Leighton P, Tilghman M, Efstratiadis A . Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith–Wiedemann and Simpson-Golabi-Behmel syndromes Genes Dev 1997 11: 3128–3142
Cano-Gauci D, Song H, Yang H et al. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome J Cell Biol 1999 146: 255–264
Acknowledgements
This work was supported by Assistance Publique-Hopitaux de Paris: Contrat de Recherche Clinique n° 97133, by the University Paris VI, Faculté Saint-Antoine (UPRESS EA 1531) and by INSERM (U515). We thank Drs Battin, Baudon, Baumann, Bensman, Blanchet, Bonneau, Brugières, Cabrol, Chatelain, Chaussain, Coutant, David, Dendale, Estéva, Faivre Gourmelen, Guillot, Heimann, Holder-Espinasse, Houang, Lacombe, Landmann-Parker, Lasfargues, Léger, Leheup, Leverger, Limal, Lyonnet Mayer, Moncla, Montagnon, Nicolino, Nivelon, Polak, Puel, Rappaport, Raux-Demay, Rocchicioli, Safar, Sarda, Sariban, Schlumberger, Tauber, Teinturier and Wagner for their help in the assessment of patients.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gaston, V., Le Bouc, Y., Soupre, V. et al. Analysis of the methylation status of the KCNQ1OT and H19 genes in leukocyte DNA for the diagnosis and prognosis of Beckwith–Wiedemann syndrome. Eur J Hum Genet 9, 409–418 (2001). https://doi.org/10.1038/sj.ejhg.5200649
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejhg.5200649
Keywords
This article is cited by
-
Maintenance of methylation profile in imprinting control regions in human induced pluripotent stem cells
Clinical Epigenetics (2022)
-
Prospective study of epigenetic alterations responsible for isolated hemihyperplasia/hemihypoplasia and their association with leg length discrepancy
Orphanet Journal of Rare Diseases (2021)
-
Meta-analysis of epigenome-wide association studies of carotid intima-media thickness
European Journal of Epidemiology (2021)
-
Clinical and molecular features of children with Beckwith-Wiedemann syndrome in China: a single-center retrospective cohort study
Italian Journal of Pediatrics (2020)
-
DNA methylation biomarkers of future health outcomes in children
Molecular and Cellular Pediatrics (2020)